Shimadzu Europe
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: E-News

E-News

FUJIFILM Yutaka

Fujifilm Irvine Scientific expands life sciences portfolio, integrates key products from Fujifilm Wako Chemicals

, 23 October 2024/in E-News /by panglobal

Fujifilm Irvine Scientific, a provider of cell culture solutions for life science and medical markets, has announced an expansion of its product portfolio through alignment with its sister company, Fujifilm Wako Chemicals U.S.A., Corp. From 1 October 2024, Fujifilm Irvine Scientific will directly promote products from three divisions of Fujifilm Wako Chemicals –Lab Automation, Lab […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/10/FUJIFILM-Yutaka.jpg 1135 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-10-23 11:36:462024-10-23 11:36:46Fujifilm Irvine Scientific expands life sciences portfolio, integrates key products from Fujifilm Wako Chemicals
Beckman Coulter BMA

Beckman Coulter and Scopio Labs expand partnership to include digital bone marrow analysis

, 23 October 2024/in E-News /by panglobal

Beckman Coulter, a prominent clinical diagnostics company, and Scopio Labs, a MedTech firm specialising in digital cell morphology solutions, have announced an expansion of their long-term partnership. The new agreement includes global distribution of Scopio’s Full-Field Bone Marrow Aspirate™ (FF-BMA) Application, which is CE-Marked for use with Scopio’s X100 and X100HT scanners.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/10/Beckman-Coulter_BMA.jpg 958 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-10-23 11:32:132024-10-23 11:32:13Beckman Coulter and Scopio Labs expand partnership to include digital bone marrow analysis
BMA image 4K

Beckman Coulter and Scopio Labs Add World’s First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership

, 16 October 2024/in E-News /by panglobal

Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, today jointly announced expansion of its long-term partnership to include a global distribution agreement of Scopio’s Full-Field Bone Marrow Aspirate™ (FF-BMA) Application. Scopio’s X100 / X100HT with FF-BMA Application are CE-Marked.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/10/BMA-image-4K.jpg 1079 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-10-16 09:01:502024-10-16 09:01:50Beckman Coulter and Scopio Labs Add World’s First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership
An artist’s impression of the Lilly Medicine Foundry

Eli Lilly to invest $4.5 billion in integrated drug discovery and manufacturing facility

drug discovery, Eli Lilly, pharmaceutical, Research, 3 October 2024/in E-News /by panglobal

Eli Lilly and Company has announced plans for a $4.5 billion (£3.6 billion) facility that integrates pharmaceutical research and manufacturing. The Lilly Medicine Foundry, revealed on 2 October 2024, will aim to streamline drug discovery and production processes. This approach could significantly accelerate the journey from drug development through clinical trials to manufacturing.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/10/Lilly-Medicine-Foundry.jpg 450 800 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-10-03 07:20:082024-10-03 07:20:08Eli Lilly to invest $4.5 billion in integrated drug discovery and manufacturing facility
Pancreatic islets

Pancreatic beta cells thrive solo, challenging established beliefs

, 23 September 2024/in E-News /by panglobal

New research from the University of Geneva suggests that pancreatic beta cells may function more effectively in isolation, potentially reshaping our understanding of diabetes treatment.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/09/Pancreatic-islets.jpg 500 1140 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-09-23 18:31:422024-09-23 18:31:42Pancreatic beta cells thrive solo, challenging established beliefs
lab enzymes

Scientists unlock new approach to target ‘undruggable’ enzymes

, 23 September 2024/in E-News /by panglobal

UCSF researchers have developed a novel method to target GTPases, a family of enzymes linked to various diseases including cancer and Parkinson’s, potentially opening new avenues for drug development.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/09/lab_enzymes.jpg 889 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-09-23 18:28:382024-09-23 18:28:38Scientists unlock new approach to target ‘undruggable’ enzymes
lancet microbiome

Experts call for standardisation in microbiome-based biomarker research

, 23 September 2024/in E-News /by panglobal

A new study highlights the potential of microbiome-based biomarkers whilst emphasising the need for validated analytical methods and international standards.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/09/lancet-microbiome.jpg 961 1281 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-09-23 13:06:082024-09-23 13:06:08Experts call for standardisation in microbiome-based biomarker research
molecules

Billions of new molecules: A quantum leap in drug discovery

, 23 September 2024/in E-News /by panglobal

ETH Zurich researchers have developed a method to synthesise and test billions of new chemical compounds in weeks, potentially accelerating drug development and expanding the range of treatable conditions.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/09/molecules.jpg 1187 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-09-23 13:02:022024-09-23 13:02:02Billions of new molecules: A quantum leap in drug discovery
patrik enfors

Neuroscientists map morphine’s pain-relieving mechanisms

, 23 September 2024/in E-News /by panglobal

Researchers at Karolinska Institutet have uncovered key neural processes behind morphine’s analgesic effects, potentially paving the way for safer pain management strategies.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/09/patrik-enfors.jpg 1144 896 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-09-23 12:58:042024-09-23 12:58:04Neuroscientists map morphine’s pain-relieving mechanisms
INDICA Lab AI

Indica Labs and Paige announce partnership to enhance AI integration in anatomic pathology

, 23 September 2024/in E-News /by panglobal

In a move set to advance the field of computational pathology, Indica Labs and Paige have announced a strategic partnership aimed at integrating Paige’s diagnostic AI models into Indica’s HALO AP workflow management software. The collaboration promises to deliver AI-enabled workflows that could significantly improve laboratory efficiency, diagnostic quality, and patient outcomes in anatomic pathology.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/09/INDICA-Lab-AI.jpg 1076 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-09-23 11:33:502024-09-23 11:33:50Indica Labs and Paige announce partnership to enhance AI integration in anatomic pathology
Page 18 of 228«‹1617181920›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

November 2025

CLi Cover nov 2025
15 December 2025

WERFEN APPLAUDS SIGNIFICANT PUBLICATION URGING ACTION ON THE RISKS OF UNDETECTED HEMOLYSIS

13 December 2025

Indero validates three-day gene expression method

12 December 2025

Johnson & Johnson acquires Halda Therapeutics for $3.05 billion

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription